BrainStorm Shareholder Seeks Access to Board’s FDA Snub Records

A BrainStorm Cell Therapeutics Inc. stockholder requested a Delaware court order the biopharmaceutical company turn over ...
Business Wire

BCLI FINAL DEADLINE NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses in Excess of $500K to Secure Counsel Before ...

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) between August 15, 2022 and ...
Business Wire

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Brainstorm Cell Therapeutics Inc. – BCLI

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Brainstorm Cell Therapeutics ...
KTLA

Brainstorm Cell Therapeutics Inc. Class Action Reminder: Contact Robbins LLP for Information About the BCLI Class Action

SAN DIEGO, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action lawsuit on behalf of persons and entities that purchased or otherwise acquired ...